Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
1999 1
2000 1
2003 4
2004 1
2008 3
2009 2
2011 1
2012 2
2013 2
2014 2
2015 3
2017 1
2018 3
2019 4
2020 4
2021 2
2022 2
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20EY, 5BAuthor
Page 1
Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia.
Arai H, Maeda K, Wakabayashi H, Naito T, Konishi M, Assantachai P, Auyeung WT, Chalermsri C, Chen W, Chew J, Chou MY, Hsu CC, Hum A, Hwang IG, Kaido T, Kang L, Kamaruzzaman SB, Kim M, Lee JSW, Lee WJ, Liang CK, Lim WS, Lim JY, Lim YP, Lo RS, Ong T, Pan WH, Peng LN, Pramyothin P, Razalli NH, Saitoh M, Shahar S, Shi HP, Tung HH, Uezono Y, von Haehling S, Won CW, Woo J, Chen LK. Arai H, et al. J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):1949-1958. doi: 10.1002/jcsm.13323. Epub 2023 Sep 5. J Cachexia Sarcopenia Muscle. 2023. PMID: 37667992 Free PMC article. Review.
Critical clinical outcomes were determined to be mortality, quality of life as assessed by tools such as EQ-5D or the Functional Assessment of Anorexia/Cachexia Therapy, and functional status as measured by the Clinical Frailty Scale or Barthel Index, with significant emph …
Critical clinical outcomes were determined to be mortality, quality of life as assessed by tools such as EQ-5D or the Functional Asse …
AMPK Activation Restores Salivary Function Following Radiation Treatment.
Meyer RK, Gilman KE, Rheinheimer BA, Meeks L, Limesand KH. Meyer RK, et al. J Dent Res. 2023 May;102(5):546-554. doi: 10.1177/00220345221148983. Epub 2023 Feb 1. J Dent Res. 2023. PMID: 36726289
Salivary gland damage following radiotherapy leads to severe and chronic hypofunction with decreased salivary output, xerostomia, impaired ability to chew and swallow, increased risk of developing oral mucositis, and malnutrition. ...
Salivary gland damage following radiotherapy leads to severe and chronic hypofunction with decreased salivary output, xerostomia, impaired a …
Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: The VICTORIA Randomized Clinical Trial.
Chew DS, Li Y, Bigelow R, Cowper PA, Anstrom KJ, Daniels MR, Davidson-Ray L, Hernandez AF, O'Connor CM, Armstrong PW, Mark DB; VICTORIA Study Group. Chew DS, et al. Circulation. 2023 Oct 3;148(14):1087-1098. doi: 10.1161/CIRCULATIONAHA.122.063602. Epub 2023 Sep 6. Circulation. 2023. PMID: 37671551 Clinical Trial.
Quality-of-life adjustments were based on prospectively collected EQ-5D-based utilities. The primary outcome was the incremental cost-effectiveness ratio, comparing vericiguat with placebo, assessed from the US health care sector perspective over a lifetime horizon. ...
Quality-of-life adjustments were based on prospectively collected EQ-5D-based utilities. The primary outcome was the incremental cost …
Effectiveness of GRACE risk score in patients admitted to hospital with non-ST elevation acute coronary syndrome (UKGRIS): parallel group cluster randomised controlled trial.
Gale CP, Stocken DD, Aktaa S, Reynolds C, Gilberts R, Brieger D, Carruthers K, Chew DP, Goodman SG, Fernandez C, Sharples LD, Yan AT, Fox K. Gale CP, et al. BMJ. 2023 Jun 14;381:e073843. doi: 10.1136/bmj-2022-073843. BMJ. 2023. PMID: 37315959 Free PMC article. Clinical Trial.
Secondary measures included the duration of hospital stay, EQ-5D-5L (five domain, five level version of the EuroQoL index), and the composite endpoint components. ...The time to the first composite cardiac event was not significantly improved by the GRS (hazard ratio 0.89, …
Secondary measures included the duration of hospital stay, EQ-5D-5L (five domain, five level version of the EuroQoL index), and the c …
Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial.
Chew DS, Li Y, Cowper PA, Anstrom KJ, Piccini JP, Poole JE, Daniels MR, Monahan KH, Davidson-Ray L, Bahnson TD, Al-Khalidi HR, Lee KL, Packer DL, Mark DB; CABANA Investigators. Chew DS, et al. Circulation. 2022 Aug 16;146(7):535-547. doi: 10.1161/CIRCULATIONAHA.122.058575. Epub 2022 Jun 21. Circulation. 2022. PMID: 35726631 Free PMC article. Clinical Trial.
Extrapolated life expectancies were estimated using age-based survival models. Quality-of-life adjustments were based on EQ-5D-based utilities measured during the trial. The primary outcome was the incremental cost-effectiveness ratio, comparing ablation with drug therapy …
Extrapolated life expectancies were estimated using age-based survival models. Quality-of-life adjustments were based on EQ-5D-based …
Effects of low and moderate refractive errors on chromatic pupillometry.
Rukmini AV, Chew MC, Finkelstein MT, Atalay E, Baskaran M, Nongpiur ME, Gooley JJ, Aung T, Milea D, Najjar RP. Rukmini AV, et al. Sci Rep. 2019 Mar 20;9(1):4945. doi: 10.1038/s41598-019-41296-w. Sci Rep. 2019. PMID: 30894608 Free PMC article.
This study included 139 participants (50 years) grouped by refractive error: moderate myopes (>-6.0D and -3.0D, n = 24), low myopes (>-3.0D and <-0.5D, n = 30), emmetropes (-0.5D and 0.5D, n = 31) and hyperopes (>0.5D and <6.0D, n = 54). …
This study included 139 participants (50 years) grouped by refractive error: moderate myopes (>-6.0D and -3.0D, n = 24), low myopes (> …
Responsiveness of the EQ-5D to HADS-identified anxiety and depression.
Whynes DK; TOMBOLA Group. Whynes DK, et al. J Eval Clin Pract. 2009 Oct;15(5):820-5. doi: 10.1111/j.1365-2753.2008.01102.x. J Eval Clin Pract. 2009. PMID: 19811595
We examined the strength of association between HADS-determined severity of distress and EQ-5D scores at recruitment and between changes in severity and in scores over time. RESULTS: A higher likelihood of HADS-identified anxiety and/or depression was associated with signi …
We examined the strength of association between HADS-determined severity of distress and EQ-5D scores at recruitment and between chan …
Health-related quality of life loss associated with first-time stroke.
Yeoh YS, Koh GC, Tan CS, Tu TM, Singh R, Chang HM, De Silva DA, Ng YS, Ang YH, Yap P, Chew E, Merchant RA, Yeo TT, Chou N, Venketasubramanian N, Lee KE, Young SH, Hoenig H, Matchar DB, Luo N. Yeoh YS, et al. PLoS One. 2019 Jan 28;14(1):e0211493. doi: 10.1371/journal.pone.0211493. eCollection 2019. PLoS One. 2019. PMID: 30689666 Free PMC article.
METHODS: The HRQoL of stroke survivors was assessed with the EQ-5D-3L index score at recruitment, for recalled pre-stroke HRQoL, and at 3 and 12 month post-stroke. ...The reduction at 3 month was associated with the reduction in all EQ-5D-3L health dimensions; reduc …
METHODS: The HRQoL of stroke survivors was assessed with the EQ-5D-3L index score at recruitment, for recalled pre-stroke HRQoL, and …
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia.
Granholm A, Kjær MN, Munch MW, Myatra SN, Vijayaraghavan BKT, Cronhjort M, Wahlin RR, Jakob SM, Cioccari L, Vesterlund GK, Meyhoff TS, Helleberg M, Møller MH, Benfield T, Venkatesh B, Hammond NE, Micallef S, Bassi A, John O, Jha V, Kristiansen KT, Ulrik CS, Jørgensen VL, Smitt M, Bestle MH, Andreasen AS, Poulsen LM, Rasmussen BS, Brøchner AC, Strøm T, Møller A, Khan MS, Padmanaban A, Divatia JV, Saseedharan S, Borawake K, Kapadia F, Dixit S, Chawla R, Shukla U, Amin P, Chew MS, Wamberg CA, Bose N, Shah MS, Darfelt IS, Gluud C, Lange T, Perner A. Granholm A, et al. Intensive Care Med. 2022 May;48(5):580-589. doi: 10.1007/s00134-022-06677-2. Epub 2022 Mar 31. Intensive Care Med. 2022. PMID: 35359168 Free PMC article. Clinical Trial.
RESULTS: We obtained vital status at 180 days for 963 of 982 patients (98.1%) in the intention-to-treat population, EQ-5D-5L index value data for 922 (93.9%) and EQ VAS data for 924 (94.1%). ...The adjusted mean differences between the 12 mg and the 6 mg groups in EQ-5D
RESULTS: We obtained vital status at 180 days for 963 of 982 patients (98.1%) in the intention-to-treat population, EQ-5D-5L index va …
Disentangling the Relationship between Frailty and Intrinsic Capacity in Healthy Community-Dwelling Older Adults: A Cluster Analysis.
Chew J, Lim JP, Yew S, Yeo A, Ismail NH, Ding YY, Lim WS. Chew J, et al. J Nutr Health Aging. 2021;25(9):1112-1118. doi: 10.1007/s12603-021-1679-2. J Nutr Health Aging. 2021. PMID: 34725670 Free article.
Cluster associations with one-year outcomes (frailty, muscle strength (grip strength, repeated chair stand test), physical performance (gait speed, Short Physical Performance Battery), function (MBI) and quality-of-life (EuroQol (EQ)-5D)) were examined using multiple linea …
Cluster associations with one-year outcomes (frailty, muscle strength (grip strength, repeated chair stand test), physical performance (gait …
44 results